Tin tức & Cập nhật

Chỉ hiển thị Multimedia

Slight changes in PSA warrant closer attention in nonmetastatic CRPC

02 Dec 2020

Men with nonmetastatic castration-resistant prostate cancer (nmCRPC) who have rapidly rising levels of prostate-specific antigen (PSA) see radiographic progression of their malignancy even without meeting the criteria set by the Prostate Cancer Working Group 2 (PCWG2), a recent study has shown.

Slight changes in PSA warrant closer attention in nonmetastatic CRPC

02 Dec 2020

COVID-19 bears heavy on cancer survivors

30 Nov 2020

The novel coronavirus disease (COVID-19) pandemic aggravates psychological symptoms among cancer survivors, reports a recent China study.

COVID-19 bears heavy on cancer survivors

30 Nov 2020

Carbon monoxide may have potent anti-breast cancer effects

29 Nov 2020

Women who have a history of carbon monoxide poisoning (COP) appear to be at a lower risk of developing breast cancer, a recent Taiwan study has found. This points to a potential protective effect of CO against breast cancer.

Carbon monoxide may have potent anti-breast cancer effects

29 Nov 2020

Fat-dissociation method speeds up CRC lymph node detection without accuracy trade-off

28 Nov 2020

A new fat-dissociation method (FM) of examining positive lymph nodes (LNs) from surgically removed mesentery reduces the overall time required for detection without sacrificing accuracy, a recent study has found.

Fat-dissociation method speeds up CRC lymph node detection without accuracy trade-off

28 Nov 2020

Late diagnosis, early menopause predict bone metastasis in breast cancer patients

27 Nov 2020 bởi

Breast cancer patients face a high risk of skeletal-related events (SREs), particularly when diagnosed at advanced stages, reports a new Indonesia study presented at the recently concluded 2020 Asia Virtual Congress of the European Society of Medical Oncology (ESMO Asia 2020). Oncological and reproductive factors seem to affect this risk and may be worth monitoring for.

Late diagnosis, early menopause predict bone metastasis in breast cancer patients

27 Nov 2020

Valproic acid may be protective against melanoma

26 Nov 2020

Exposure to valproic acid seems to reduce the risk of melanoma, a recent study has found. That this may be due to residual confounding cannot be ruled out, however.

Valproic acid may be protective against melanoma

26 Nov 2020

Subgroup findings boost ribociclib-letrozole potential in Asians with HR+, HER2– advanced breast cancer

26 Nov 2020 bởi

In a subgroup analysis of the phase IIIb CompLEEment-1 trial, ribociclib plus letrozole showed a manageable safety profile in Asian patients with hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2−) advanced breast cancer (ABC).

Subgroup findings boost ribociclib-letrozole potential in Asians with HR+, HER2– advanced breast cancer

26 Nov 2020

Lung cancer not uncommon after kidney transplant

26 Nov 2020 bởi

While lung cancer is relatively rare among kidney transplant recipients, it remains a dangerous complication, carrying high rates of metastasis and mortality, according to a Philippine case series presented at the recently concluded 2020 Asia Virtual Congress of the European Society of Medical Oncology (ESMO Asia 2020)

Lung cancer not uncommon after kidney transplant

26 Nov 2020

Inflammatory markers tied to better HCC outcomes after nivolumab treatment

26 Nov 2020

Following treatment with nivolumab, a programmed death (PD)-1 inhibitor, the expression of inflammatory markers seems to correlate with better survival and treatment response in hepatocellular carcinoma (HCC) patients, a recent study has shown. This suggests that antitumour inflammatory mechanisms play a role in the action of nivolumab.

Inflammatory markers tied to better HCC outcomes after nivolumab treatment

26 Nov 2020

NALA: Neratinib–capecitabine role in HER2-positive MBC confirmed in Asians

25 Nov 2020 bởi

The neratinib/capecitabine combination still confers survival advantage over lapatinib plus capecitabine in the subgroup of Asian patients with heavily treated HER2-positive metastatic breast cancer (MBC), according to an exploratory analysis of the phase III NALA trial.

NALA: Neratinib–capecitabine role in HER2-positive MBC confirmed in Asians

25 Nov 2020

Tin tức & Cập nhật

Lọc theo Chuyên ngành:

Chuyên ngành:

Slight changes in PSA warrant closer attention in nonmetastatic CRPC

Slight changes in PSA warrant closer attention in nonmetastatic CRPC

COVID-19 bears heavy on cancer survivors

COVID-19 bears heavy on cancer survivors

Carbon monoxide may have potent anti-breast cancer effects

Carbon monoxide may have potent anti-breast cancer effects

Fat-dissociation method speeds up CRC lymph node detection without accuracy trade-off

Fat-dissociation method speeds up CRC lymph node detection without accuracy trade-off

Late diagnosis, early menopause predict bone metastasis in breast cancer patients

Late diagnosis, early menopause predict bone metastasis in breast cancer patients

Valproic acid may be protective against melanoma

Valproic acid may be protective against melanoma

Subgroup findings boost ribociclib-letrozole potential in Asians with HR+, HER2– advanced breast cancer

Subgroup findings boost ribociclib-letrozole potential in Asians with HR+, HER2– advanced breast cancer

Lung cancer not uncommon after kidney transplant

Lung cancer not uncommon after kidney transplant

Inflammatory markers tied to better HCC outcomes after nivolumab treatment

Inflammatory markers tied to better HCC outcomes after nivolumab treatment

NALA: Neratinib–capecitabine role in HER2-positive MBC confirmed in Asians

NALA: Neratinib–capecitabine role in HER2-positive MBC confirmed in Asians